CRP and metabolic dysfunction-associated steatotic liver disease: Third, the noticeable limitation of our study was the potential for bias due to the inability to fully adjust for confounders, such as CRP [69] and non-alcoholic fatty liver disease (NAFLD) [70], which might bias the results toward the exaggeration or underestimation of risk estimates, therefore, the positive effect of increasing GGT level on CV mortality could be attributed to other risk factors.